Hospital
Montgomery General Hospital, INC.
Montgomery General Hospital, INC. was paid $1.81M by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.
33Billing provider infoMONTGOMERY GENERAL HOSPITAL, INC.
OLNEY, MD 20832
OLNEY, MD 20832
33aNPI1114922341assigned 06/15/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.81M
24GClaims53,868
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#22 of 69
Median peer was paid$870K
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,950 | $167K | |
| 2019 | 7,182 | $215K | |
| 2020 | 5,371 | $253K | |
| 2021 | 9,026 | $402K | |
| 2022 | 8,962 | $307K | |
| 2023 | 7,868 | $291K | |
| 2024incomplete | 6,509 | $178K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 3,207 | 2,919 | $485K |
| G0378 | Hospital observation service, per hour | 26% | 650 | 588 | $464K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 3,070 | 2,703 | $368K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 1,691 | 1,528 | $278K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 5.6% | 2,091 | 1,735 | $102K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 7,880 | 5,846 | $22K |
| 80053 | Comprehensive metabolic panel | 1.2% | 5,572 | 4,480 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,232 | 3,630 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,085 | 1,913 | $5K |
| 84484 | <1% | 2,716 | 2,292 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,682 | 1,492 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 181 | 149 | $5K |
46 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 301 | $5K |
| 81001 | <1% | 3,135 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,415 | $4K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 117 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 35 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 65 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,269 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,344 | $2K |
| 87400 | <1% | 36 | $2K | |
| 83690 | <1% | 1,322 | $1K | |
| 87581 | <1% | 35 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 35 | $1K |
| 83735 | <1% | 2,139 | $1K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 220 | $986.65 |
| 85610 | <1% | 1,403 | $821.95 | |
| 83605 | <1% | 331 | $715.43 | |
| 82550 | <1% | 568 | $569.17 | |
| 82077 | <1% | 56 | $348.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 29 | $347.16 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 150 | $220.82 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 81 | $217.44 |
| 83880 | <1% | 391 | $156.75 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 334 | $145.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 188 | $99.03 |
| 85730 | <1% | 121 | $97.95 | |
| 85027 | <1% | 50 | $86.89 | |
| 84703 | <1% | 13 | $63.44 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 111 | $35.98 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 929 | $31.21 |
| J2704 | Injection, propofol, 10 mg | 0% | 41 | $0.00 |
| J3490 | Unclassified drugs | 0% | 135 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 376 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 99 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 12 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 18 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 24 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 100 | $0.00 |
| 87486 | 0% | 19 | $0.00 | |
| 82553 | 0% | 16 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 63 | $0.00 |
| 87077 | 0% | 12 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 478 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 106 | $0.00 |
| 80076 | 0% | 58 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 19 | $0.00 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOGARTY, JOHN (SR. VICE PRESIDENT/ CFO)